Delivery Order SPE2DB25D3109-SPE2DB25FPJSU

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,105.83, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, worth $999,999,999 and running through November 2026. The award covers the supply of 4566833257 - VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, to support...
This federal contract award, valued at $1,065.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order, with a period of performance through December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,497.12 firm fixed-price delivery order is for the supply of VALSARTAN-HCTZ 160-25 MG TAB 90S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,985.62 firm fixed price delivery order is for the supply of 4566846812 VALSARTAN-HCTZ 80-12.5 MG TAB 90S, with a period of performance through January 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG tablets in 90-count packages, with a ceiling value of $29,970.35. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,222.53 Firm Fixed Price Delivery Order is for the supply of Valsartan-HCTZ 320-25 mg tablets, a cardiovascular medication. The contract has a period of performance through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,055.94 Delivery Order contract is for the supply of Valsartan-HCTZ 320-25 mg tablets, a cardiovascular medication. The contract is a Firm Fixed Price agreement with a completion date of December 13, 2024. It is not designated as a set-aside contract. This Delivery Order is likely part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,917.45 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 320-12.5 mg tablets, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $3,250.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets, a cardiovascular medication, in 90-count bottles. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.26 firm fixed-price delivery order is for 4566737140 - VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPJSU
    Delivery Order

This federal contract award, valued at $5,893.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of January 13, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:29 AM